Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis

Cardiovasc Res. 2015 Mar 1;105(3):361-71. doi: 10.1093/cvr/cvv003. Epub 2015 Jan 12.

Abstract

Aims: The adhesion of circulating monocytes to endothelial cells (ECs) is an early and critical event in the formation of atherosclerotic plaques. Hydrogen peroxide-inducible clone 5 (Hic-5) serves as an adaptor molecule in cell adhesion complexes. However, the role of endothelial Hic-5 in monocyte-EC interaction and atherogenesis remains unclear. We examined the roles of endothelial Hic-5 in monocyte-EC interaction and atherogenesis using mouse models of atherosclerosis and cultured human umbilical vein endothelial cells (HUVECs).

Methods and results: Hic-5 was expressed in ECs, but not in monocytes/macrophages. An ex vivo monocyte adhesion assay revealed that adhesion of THP-1 monocytes to aortas isolated from Apoe(-/-) and LDLR(-/-) mice stimulated by TNF-α or oxidized LDL was suppressed by Hic-5 deficiency. Scanning electron microscopic observations of aortas harvested from Apoe(-/-) mice revealed that TNF-α- or oxidized LDL-induced microvilli-like structures were markedly suppressed by Hic-5 deficiency. Relative Hic-5 deficiency suppressed 60% of the atherosclerotic lesions in aortas from Apoe(-/-) and LDLR(-/-) mice. In contrast, overexpression of Hic-5 in HUVECs promoted induction of microvilli-like structures and adherence of THP-1 cells in an adhesion receptor such as intercellular adhesion molecule-1- and vascular cell adhesion molecule-1-dependent manner.

Conclusion: Hic-5 in ECs plays an important role in the formation of microvilli-like structures and in the interaction between ECs and monocytes, leading to monocyte recruitment and subsequent development of atherosclerosis.

Keywords: Atherosclerosis; Endothelial cells; Microvilli-like structures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Aorta / metabolism*
  • Aorta / ultrastructure
  • Aortic Diseases / genetics
  • Aortic Diseases / metabolism*
  • Aortic Diseases / pathology
  • Aortic Diseases / prevention & control
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / genetics
  • Atherosclerosis / genetics
  • Atherosclerosis / metabolism*
  • Atherosclerosis / pathology
  • Atherosclerosis / prevention & control
  • Cell Adhesion*
  • Cells, Cultured
  • Coculture Techniques
  • Cytoskeletal Proteins / deficiency
  • Cytoskeletal Proteins / genetics
  • Cytoskeletal Proteins / metabolism*
  • DNA-Binding Proteins / deficiency
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Disease Models, Animal
  • Endothelial Cells / metabolism*
  • Endothelial Cells / pathology
  • Female
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Intercellular Adhesion Molecule-1 / metabolism
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • LIM Domain Proteins / deficiency
  • LIM Domain Proteins / genetics
  • LIM Domain Proteins / metabolism*
  • Lipoproteins, LDL / metabolism
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microvilli / metabolism
  • Middle Aged
  • Monocytes / metabolism*
  • Monocytes / pathology
  • RNA Interference
  • Receptors, LDL / deficiency
  • Receptors, LDL / genetics
  • Signal Transduction
  • Transfection
  • Tumor Necrosis Factor-alpha / metabolism
  • Vascular Cell Adhesion Molecule-1 / metabolism

Substances

  • Apolipoproteins E
  • Cytoskeletal Proteins
  • DNA-Binding Proteins
  • ICAM1 protein, human
  • Intracellular Signaling Peptides and Proteins
  • LIM Domain Proteins
  • Lipoproteins, LDL
  • Receptors, LDL
  • TGFB1I1 protein, human
  • Tgfb1i1 protein, mouse
  • Tumor Necrosis Factor-alpha
  • Vascular Cell Adhesion Molecule-1
  • oxidized low density lipoprotein
  • Intercellular Adhesion Molecule-1